Stock listing
TRVI Stock Price, News, Filings & Events — Trevi Therapeutics, Inc.
Selected listing: TRVI · NASDAQ · USD · US
This page tracks Trevi Therapeutics, Inc.'s TRVI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TRVI:NASDAQ. TRVI:NASDAQ is the stock-level entry point for investors researching Trevi Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Trevi Therapeutics, Inc. is a public company traded under the ticker TRVI in the American market. The company has a market capitalization of approximately $2.53 billion. Trevi focuses on developing innovative therapies to address unmet medical needs.
- Ticker
- TRVI:NASDAQ
- Asset type
- Stock
- Market cap
- $2.27B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Trevi Therapeutics, Inc. TRVI:NASDAQ stock context
This page tracks Trevi Therapeutics, Inc.'s TRVI:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following TRVI:NASDAQ. TRVI:NASDAQ is the stock-level entry point for investors researching Trevi Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Trevi Therapeutics, Inc. is a public company traded under the ticker TRVI in the American market. The company has a market capitalization of approximately $2.53 billion. Trevi focuses on developing innovative therapies to address unmet medical needs.
Latest news from Trevi Therapeutics, Inc.
Trevi Therapeutics Announces Upcoming Presentations at the European Respiratory Society (ERS) Congress 2026
August 26, 2026
Trevi Therapeutics : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Trevi Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Updates
August 6, 2026
Trevi Therapeutics to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026
July 30, 2026
Trevi Therapeutics Announces Upcoming June and July Event Schedule
June 17, 2026
Trevi Therapeutics, Inc. earnings calls
Trevi Therapeutics, Inc. (TRVI) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Trevi Therapeutics, Inc. (TRVI) Q1 2026 Earnings Call
May 5, 2026 · Replay with transcript and chapters
Trevi Therapeutics, Inc. (TRVI) Q4 2025 Earnings Call
March 17, 2026 · Replay with transcript and chapters
Trevi Therapeutics, Inc. (TRVI) Q3 2025 Earnings Call
November 13, 2025 · Replay with transcript and chapters
Trevi Therapeutics, Inc. (TRVI) Q2 2025 Earnings Call
August 7, 2025 · Replay with transcript and chapters
Trevi Therapeutics, Inc. (TRVI) Q1 2025 Earnings Call
May 8, 2025 · Replay with transcript and chapters
Research Trevi Therapeutics, Inc.
Trevi Therapeutics, Inc. investor report
Review AI stock analysis and investor report context for TRVI:NASDAQ.
Trevi Therapeutics, Inc. company profile
View the public company page for Trevi Therapeutics, Inc. on 6ix.
Trevi Therapeutics, Inc. news
Read company news and market updates connected to Trevi Therapeutics, Inc..
Trevi Therapeutics, Inc. investor events
Find investor webinars, events, and replay context for Trevi Therapeutics, Inc..